References

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2024 · External reference

Immune checkpoint inhibitors in the treatment of cancer

2022 · External reference

Immune checkpoint inhibitors in cancer therapy

10.3390/curroncol29050247 · 2022 · External reference

Effects of malnutrition on the immune system and infection and the role of nutritional strategies regarding improvements in children’s health status: a literature review

10.3390/nu16010001 · 2023 · External reference

Decreased appetite in cancer patients treated with immune checkpoint inhibitors (ICIs): the MOUSEION-012 systematic review and meta-analysis

10.1016/j.clnesp.2025.10.031 · 2025 · External reference

Nutritional assessment in cancer patients

10.1007/978-3-031-27156-4_14 · 2023 · External reference

Understanding tumor anabolism and patient catabolism in cancer-associated cachexia

2017 · External reference

Cancer cachexia, recent advances, and future directions

10.1097/ppo.0000000000000100 · 2015 · External reference

Cancer cachexia in adult patients: ESMO Clinical Practice guidelines☆

10.1016/j.esmoop.2021.100092 · 2021 · External reference

Nutritional status and interventions for patients with cancer - a systematic review

10.1016/j.jgo.2020.06.020 · 2021 · External reference

Prevalence and prognostic impact of malnutrition at cancer diagnosis: a prospective cohort study

10.1016/j.clnesp.2026.102943 · 2026 · External reference

Prognostic effect of weight loss prior to chemotherapy in cancer patients

10.1016/s0149-2918(05)80001-3 · 1980 · External reference

Nutritional treatment of patients with colorectal cancer

10.3390/ijerph19116881 · 2022 · External reference

Nutritional assessment tools for patients with cancer: a narrative review

10.1007/s11596-023-2808-4 · 2024 · External reference

Prevalence of severe malnutrition in cancer patients: a systematic review and meta-analysis

10.1186/s41043-025-01006-x · 2025 · External reference

Prognostic relevance of prognostic nutritional indices in gastric or gastro-esophageal junction cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

10.3389/fimmu.2024.1382417 · 2024 · External reference

The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: a narrative review

10.3390/nu13061980 · 2021 · External reference

Dietary interventions in cancer treatment and response: a comprehensive review

10.3390/cancers14205149 · 2022 · External reference

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

2021 · External reference

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

2016 · External reference

Measuring inconsistency in meta-analyses

10.1136/bmj.327.7414.557 · 2003 · External reference

Forest plots: trying to see the wood and the trees

10.1136/bmj.322.7300.1479 · 2001 · External reference

Bias in meta-analysis detected by a simple, graphical test

10.1136/bmj.315.7109.629 · 1997 · External reference

Body composition change indices combined with prognostic nutritional index predicts the clinical outcomes of patients with gastric cancer treated with immune checkpoint inhibitor

10.1002/cam4.7110 · 2024 · External reference

The prognostic nutritional index in patients with microsatellite instability-high metastatic gastric or gastroesophageal cancers receiving immune checkpoint inhibitors

10.1016/j.dld.2024.05.005 · 2025 · External reference

Nutritional status as a predictive biomarker for immunotherapy outcomes in advanced head and neck cancer

10.3390/cancers13225772 · 2021 · External reference

Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitors

10.2217/bmm-2020-0674 · 2021 · External reference

Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patients

10.1016/j.oraloncology.2023.106364 · 2023 · External reference

Predictive impact of prognostic nutritional index on pembrolizumab for metastatic urothelial carcinoma resistant to platinum-based chemotherapy

10.21873/anticanres.14922 · 2021 · External reference

Predictive value of prognostic nutritional index (PNI) in recurrent or unresectable hepatocellular carcinoma received anti-PD1 therapy

10.1186/s12885-023-11166-w · 2023 · External reference

Real-world efficacy data and predictive clinical parameters for treatment outcomes in advanced esophageal squamous cell carcinoma treated with immune checkpoint inhibitors

10.4143/crt.2020.1198 · 2022 · External reference

Clinical impact of prognostic nutrition index for advanced gastric cancer patients with peritoneal metastases treated nivolumab monotherapy

10.4068/cmj.2022.58.1.24 · 2022 · External reference

Predictive value of inflammation and nutritional index in immunotherapy for stage IV non-small cell lung cancer and model construction

2024 · External reference

Prognostic nutritional index identifies risk of early progression and survival outcomes in advanced Non-small cell lung cancer patients treated with PD-1 inhibitors

10.7150/jca.55936 · 2021 · External reference

Comparison of the prognostic value of inflammation-based scores in patients with hepatocellular carcinoma after Anti-PD-1 therapy

10.2147/jir.s325600 · 2021 · External reference

Prognostic significance of nutritional indices in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors

10.1080/00016489.2023.2288910 · 2023 · External reference

Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patients

10.1002/cam4.6110 · 2023 · External reference

Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors

10.1007/s00262-020-02585-w · 2020 · External reference

Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatments

10.21037/tlcr-21-710 · 2021 · External reference

Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors

10.1016/j.lungcan.2019.08.006 · 2019 · External reference

Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer

10.1016/j.esmoop.2022.100445 · 2022 · External reference

Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors

10.3389/fnut.2022.1038118 · 2022 · External reference

Prospective validation study of nutritional and immunological predictors in immune checkpoint inhibitor efficacy for non-small cell lung cancer

10.1002/ijc.70170 · 2026 · External reference

Nutrition’s checkpoint inhibition: the impact of nutrition on immunotherapy outcomes

10.1016/j.ygyno.2024.07.685 · 2024 · External reference

Effect of prognostic nutrition index in gastric or gastro-oesophageal junction cancer patients undergoing nivolumab monotherapy

10.21873/invivo.12292 · 2021 · External reference

Inflammation-based scores predict responses to PD-1 inhibitor treatment in intrahepatic cholangiocarcinoma

10.2147/jir.s385921 · 2022 · External reference

Prognostic nutritional index associates with immunotherapy response in patients with metastatic biliary tract cancer

10.1080/01635581.2022.2153880 · 2023 · External reference

Systemic inflammatory score predicts response and prognosis in patients with lung cancer treated with immunotherapy

10.21873/anticanres.15158 · 2021 · External reference

Prognostic nutritional index predicts outcome of PD-L1 negative and MSS advanced cancer treated with PD-1 inhibitors

2022 · External reference

Dissecting the impact of controlling nutritional status (CONUT) score on survival outcomes and immune-inflammatory profiles in patients with advanced NSCLC undergoing first-line immunotherapy

10.1136/jitc-2025-013045 · 2026 · External reference

Impact of baseline nutritional status, psychological health, fatigue, and insomnia on outcomes of immune checkpoint inhibitors in advanced non-small cell lung cancer: a retrospective cohort study

10.1002/kjm2.70097 · 2026 · External reference

The growing role of precision and personalized medicine for cancer treatment

2018 · External reference

The importance of identifying and validating prognostic factors in oncology

10.1053/j.seminoncol.2010.04.001 · 2010 · External reference

Cancer cachexia: new insights and future directions

10.3390/cancers15235590 · 2023 · External reference

Nutrition in oncology: overcoming challenges to optimize the patient journey from prehabilitation to rehabilitation

10.1007/s40487-025-00358-y · 2025 · External reference

Peripheral lymphocyte count as a surrogate marker of immune checkpoint inhibitor therapy outcomes in patients with non-small-cell lung cancer

10.1038/s41598-021-04630-9 · 2022 · External reference

Prognostic nutritional index and the survival of patients with hepatocellular carcinoma on immune checkpoint inhibitors: a meta-analysis

10.1186/s12885-025-15310-6 · 2025 · External reference

Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia

10.1002/jcsm.12528 · 2020 · External reference

The malnutrition universal screening tool (MUST) and a nutrition education program for high risk cancer patients: strategies to improve dietary intake in cancer patients

10.7603/s40681-015-0017-6 · 2015 · External reference

Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials

10.1016/s0261-5614(02)00214-5 · 2003 · External reference

The mini nutritional assessment (MNA) and its use in grading the nutritional state of elderly patients

10.1016/s0899-9007(98)00171-3 · 1999 · External reference

Malnutrition screening and assessment

10.3390/nu14122392 · 2022 · External reference

Nutritional risk screening and assessment

10.3390/jcm8071065 · 2019 · External reference

Body composition techniques

10.4103/ijmr.ijmr_1777_18 · 2018 · External reference

Prognostic significance of nutritional and inflammatory markers in colorectal cancer

10.5306/wjco.v16.i6.104958 · 2025 · External reference